港股公告掘金 | 蒙牛乳业预计年度股东应占利润将约为14亿元至 16亿元

智通财经03-09

重大事项：恒瑞医药(01276)：阿得贝利单抗注射液获得药物临床试验批准通知书安井食品(02648)拟向河南子公司增资1.2亿元轩竹生物-B(02575)获纳入港股通股票名单派格生物医药-B(02565)：派格生物新一代GLP-1(CR059)首次人体试验取得一个月临床观察结果长风药业(02652)获纳入沪港通及深港通的港股通标的证券名单滨海投资(02886)获提供不超过4500万美元及1.73...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2618369053?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-03-09 09:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2618369053","market":"us","top_or_hot":-1,"title":"港股公告掘金 | 蒙牛乳业预计年度股东应占利润将约为14亿元至 16亿元","media":"智通财经","content":"<div>\n<p>重大事项：恒瑞医药(01276)：阿得贝利单抗注射液获得药物临床试验批准通知书安井食品(02648)拟向河南子公司增资1.2亿元轩竹生物-B(02575)获纳入港股通股票名单派格生物医药-B(02565)：派格生物新一代GLP-1(CR059)首次人体试验取得一个月临床观察结果长风药业(02652)获纳入沪港通及深港通的港股通标的证券名单滨海投资(02886)获提供不超过4500万美元及1.73...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1411397.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股公告掘金 | 蒙牛乳业预计年度股东应占利润将约为14亿元至 16亿元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股公告掘金 | 蒙牛乳业预计年度股东应占利润将约为14亿元至 16亿元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-09 09:03 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1411397.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>重大事项：恒瑞医药(01276)：阿得贝利单抗注射液获得药物临床试验批准通知书安井食品(02648)拟向河南子公司增资1.2亿元轩竹生物-B(02575)获纳入港股通股票名单派格生物医药-B(02565)：派格生物新一代GLP-1(CR059)首次人体试验取得一个月临床观察结果长风药业(02652)获纳入沪港通及深港通的港股通标的证券名单滨海投资(02886)获提供不超过4500万美元及1.73...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1411397.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1521","symbol_name":"挪威政府全球养老基金持仓","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1411397.html","article_id":"2618369053","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2618369053","pubTimestamp":1773018197,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"重大事项：恒瑞医药(01276)：阿得贝利单抗注射液获得药物临床试验批准通知书安井食品(02648)拟向河南子公司增资1.2亿元轩竹生物-B(02575)获纳入港股通股票名单派格生物医药-B(02565)：派格生物新一代GLP-1(CR059)首次人体试验取得一个月临床观察结果长风药业(02652)获纳入沪港通及深港通的港股通标的证券名单滨海投资(02886)获提供不超过4500万美元及1.73亿","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1521":"挪威政府全球养老基金持仓","LU0348788117.USD":"ALLIANZ EMERGING ASIA EQUITY \"A\" (USD) INC","IE00B29SXG58.USD":"FSSA CHINA FOCUS \"I\" (USD) ACC","VXUS":"国际股票ETF-Vanguard","LU0651946864.USD":"贝莱德新兴市场股票收益A2","LU0672654166.SGD":"FTIF - Templeton Asian Growth A (acc) SGD-H1","IE0009570106.USD":"FSSA ASIA OPPORTUNITIES \"I\" (USD) ACC","LU0737861699.HKD":"FIDELITY CHINA FOCUS \"A \" (HKD) ACC","IE00B031J352.USD":"FSSA GREATER CHINA GROWTH \"I\" (USD) INC","LU1048588211.SGD":"Blackrock Asian Dragon A2 SGD-H","02652":"长风药业","LU0359201612.USD":"贝莱德中国基金A2","LU1224709979.USD":"FIDELITY CHINA FOCUS \"A\" (USD) ACC","LU0370786039.SGD":"Fidelity Greater China A-SGD","LU1115378108.SGD":"Eastspring Investments - Global Emerging Markets Dynamic AS SGD","IE0008368742.USD":"首域中国增长基金I Acc","SG9999002828.SGD":"Eastspring Investments Unit Trusts - Dragon Peacock A SGD","LU0594300419.USD":"富达中国消费基金A","LU0072462343.USD":"贝莱德亚洲巨龙基金","VT":"世界全股市ETF-Vanguard","LU0650527681.SGD":"Fidelity China Consumer A-SGD","IE00B97KM107.HKD":"FSSA ASIAN EQUITY PLUS \"I\" (HKD) ACC","IE00B031HY20.USD":"FSSA CHINA GROWTH \"I\" (USD) INC","BK1237":"包装食品与肉类","HK0000306701.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) INC","02575":"轩竹生物-B","02319":"蒙牛乳业","LU2045819591.USD":"Natixis WCM Global Emerging Markets Equity R/A USD","LU0128522157.USD":"TEMPLETON ASIAN GROWTH \"A\" ACC","BK1191":"制药","LU1769817096.USD":"UBS (LUX) EQUITY SICAV - GLOBAL EMERG MARKETS OPPO \"P\" (USD) INC","LU0106959298.USD":"UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) \"P\" (USD) ACC","LU2125910500.SGD":"Natixis WCM Global Emerging Markets Equity H-R/A SGD","LU0287142896.SGD":"Fidelity China Focus A-SGD","LU1769817179.HKD":"UBS (LUX) EQUITY SICAV - GLOBAL EMERG MARKETS OPPO \"P\" (HKD) INC","BK1553":"奶制品股","IE0032834883.USD":"FSSA ASIAN EQUITY PLUS \"I\" (USD) INC","LU0359201885.HKD":"BGF CHINA \"A2\" (HKD) ACC","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","LU0251143458.SGD":"Fidelity Emerging Markets A-SGD","LU0211977185.USD":"EASTSPRING INVESTMENTS GREATER CHINA EQUITY \"A\" ACC","IE00B0169L03.USD":"FSSA ASIA FOCUS FUND \"I\" (USD) ACC","LU0029875118.USD":"TEMPLETON ASIAN GROWTH \"A\" INC","LU0163747925.USD":"EASTSPRING INVESTMENTS ASIAN EQUITY A ACC","LU0259732245.USD":"EASTSPRING INVESTMENTS DRAGON PEACOCK A","HK0000320264.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) ACC","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","LU0315179316.USD":"EASTSPRING INVESTMENTS ASIAN DYNAMIC \"A\" (USD) ACC","BK1597":"三胎概念","LU0823426308.USD":"法巴中国股票基金"},"translate_title":"Hong Kong Stock Announcement Nuggets | Mengniu Dairy expects annual profit attributable to shareholders to be about 1.4 billion to 1.6 billion yuan","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VT":1.5,"VXUS":1.5,"02652":0.9,"02575":0.9,"02319":1.5},"content_text":"重大事项：恒瑞医药(01276)：阿得贝利单抗注射液获得药物临床试验批准通知书安井食品(02648)拟向河南子公司增资1.2亿元轩竹生物-B(02575)获纳入港股通股票名单派格生物医药-B(02565)：派格生物新一代GLP-1(CR059)首次人体试验取得一个月临床观察结果长风药业(02652)获纳入沪港通及深港通的港股通标的证券名单滨海投资(02886)获提供不超过4500万美元及1.73亿元的多种货币定期贷款融资和誉-B(02256)：《柳叶刀》(The Lancet)发布贝捷迈®全球III期MANEUVER研究结果经营业绩：越秀地产(00123)前2个月累计合同销售金额约为71.06亿元蒙牛乳业(02319)预计年度股东应占利润将约为14亿元至 16亿元东风集团股份(00489)前2个月累计汽车销量为228,518辆 同比增长约1.2%上美股份(02145)发盈喜，预期2025年度利润约11.4亿元至11.6亿元 同比增加约41.9%至44.4%龙湖集团(00960)前2个月累计实现总合同销售金额44.5亿元中兴通讯(00763)发布2025年度业绩 归母净利润56.18亿元 同比下降33.32%徽商银行(03698)发布正面盈利预告 2025年净利润约169.3亿元 同比增长约6.3%新鸿基公司(00086)发盈喜 预计2025年度股东应占综合溢利将不少于15亿港元","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2618369053","isCrawlerRequest":true}